Skip to main content
Clinical Trials/NCT03860181
NCT03860181
Completed
Not Applicable

Investigation of a New Skin Closure Device, Dermabond PRINEO, for Total Shoulder Arthroplasty: A Randomized, Controlled Trial

Medical University of South Carolina1 site in 1 country89 target enrollmentStarted: March 25, 2019Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
89
Locations
1
Primary Endpoint
Comparing Patient Satisfaction Ratings Between D.PRINEO and Controls

Overview

Brief Summary

This is a research study to find out whether wound closure (the process of closing the surgical wound after the procedure is complete) with Dermabond PRINEO Skin Closure System (PRINEO) will be faster and improve wound healing compared to standard closing methods after total shoulder replacement. The PRINEO system involves using running stitches to close the wound, and then taping over the sutures with a sticky film that holds the wound closed.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Comparing Patient Satisfaction Ratings Between D.PRINEO and Controls

Time Frame: 3 months post-operatively

Patient satisfaction ratings were on a scale from 0-10, where 0 = very dissatisfied and 10 = very satisfied.

Mean Closure Time Per Centimeter of Incision

Time Frame: Immediate/at time of surgery

This closure time was measured from the first stitch for closure to the application of the wound dressing. The incision length was measured immediately after closure.

Comparison of the Total Cost of Wound Closure When Using Dermabond PRINEO Versus the Surgeon's Control.

Time Frame: 3 months post-operative

Closure cost was calculated by evaluating the cost of wound closure products ($) per patient, plus the cost of the operating room ($) per minute, multiplied by the closure time (minutes) per centimeter of incision length, then multiplied by the average incision length (cm) per patient.

Secondary Outcomes

  • Median Scar Assessment (POSAS) by Plastic Surgeon(Up to 3 months post surgery)
  • Median Overall Opinion Score Reported by Operating Surgeon(Up to 3 months)
  • Median Overall Opinion Score Reported by Plastic Surgeons(Up to 3 months)
  • Wound Cosmesis (MHCS) Score by Plastic Surgeon(Up to 3 months post surgery)
  • Median Wound Inflammation Score (AIRE) Reported by Operating Physician(Up to 3 months post surgery)
  • Median Scar Assessment (POSAS) by Operating Surgeon(Up to 3 months post surgery)
  • Wound Cosmesis (MHCS) Score by Operating Physician(Up to 3 months post surgery)
  • Differences Between Patient and Surgeon Total POSAS Scores(3 months post-operatively)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Josef Eichinger

Professor

Medical University of South Carolina

Study Sites (1)

Loading locations...

Similar Trials